In the current study, IHC expression of MSH2 and MLH1 was evaluated, in terms of their deficiency in prostatic adenocarcinoma, as they are known to play an important role in carcinogenesis, via MSI, particularly defects within the MSH2 gene. Here, MLH1 is linked to prostate adenocarcinoma.